Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Henry Meds vs TeleHealth Med

Henry Meds
Graded #46

Higher grade

vs+11.200000000000003
TeleHealth Med
Graded #210

Lower grade

The verdict

Henry Meds takes it — 77.3/100 to 66.1/100.

Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A flat-fee compounded pioneer — simple, but priced at the higher end of the board now.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleHealth Med +2
72
74
Dose & formulationHenry Meds +17
80
63
Clinical oversightHenry Meds +4
80
76
Labs & monitoringHenry Meds +26
78
52
FulfillmentHenry Meds +15
78
63
Contract termsHenry Meds +23
78
55
Henry Meds · left barTeleHealth Med · right bar

The numbers

MetricHenry MedsTeleHealth Med
WeighScore77.3/10066.1/100
GradeC+C
Scorecard rank#46#210
Semaglutide$249/mo$147/mo (starting dose, compounded)
Tirzepatide$349/moNot disclosed
CoverageMulti-stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Henry Meds

Graded #46 · C+

Strengths

  • Simple flat-fee model
  • Established brand
  • Both molecules

Where it loses points

  • Higher pricing than newer entrants
  • Compounded only
TeleHealth Med

Graded #210 · C

Strengths

  • Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
  • Publishes the FDA compounded-medication disclaimer
  • 503A pharmacy designation stated in the FAQ
  • Honest disclosure that testimonials are compensated and results aren't independently verified
  • Both injectable and sublingual forms offered

Where it loses points

  • Specific 503A pharmacy partner not named
  • LegitScript ID number not shown in text — only a verification link
  • Full states-served list not disclosed
  • Named medical director not disclosed
  • Dose tiers beyond the $147/mo starting price not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard